N
Nils Bögeholz
Researcher at University of Münster
Publications - 40
Citations - 318
Nils Bögeholz is an academic researcher from University of Münster. The author has contributed to research in topics: Atrial fibrillation & Sudden cardiac death. The author has an hindex of 10, co-authored 38 publications receiving 244 citations.
Papers
More filters
Journal ArticleDOI
Divergent Electrophysiological Effects of Loperamide and Naloxone in a Sensitive Whole-Heart Model.
Julian Wolfes,Christian Ellermann,Sophie Burde,Patrick Leitz,Nils Bögeholz,Kevin Willy,Michael Fehr,Florian Reinke,Lars Eckardt,Gerrit Frommeyer +9 more
TL;DR: This is the first experimental study that investigated the effects of loperamide and naloxone in a whole-heart model and led to a significant increase in action potential duration and QT interval and the number of ventricular tachycardias was significantly increased.
Journal ArticleDOI
Occurrence of primarily noninducible atrioventricular nodal reentry tachycardia after radiofrequency delivery in the slow pathway region during empirical slow pathway modulation.
Felix K. Wegner,Nils Bögeholz,Patrick Leitz,Gerrit Frommeyer,Dirk G. Dechering,Simon Kochhäuser,Philipp S. Lange,Julia Köbe,Kristina Wasmer,Gerold Mönnig,Lars Eckardt,Christian Pott +11 more
TL;DR: The first‐line therapy for atrioventricular nodal reentry tachycardia (AVNRT) is catheter‐based slow pathway modulation, and an empirical slow pathways modulation (ESPM) may be considered in patients with dual atriOVentricular nodsal physiology and/or a typical electrocardiogram (ECG).
Journal ArticleDOI
Supraventricular extrasystole due to 1:2 atrioventricular conduction: procedural characteristics and long term follow-up of slow pathway modulation
C Pott,F. Wegner,Nils Bögeholz,Alicia Jeanette Fischer,E. Kaya,Peter Milberg,J. Koebe,Kristina Wasmer,G. Moennig,Lars Eckardt +9 more
TL;DR: In this article, the authors present procedural characteristics and long-term follow-up in a series of five patients who underwent radiofrequency modulation of the slow pathway (SPM) for the treatment of 1:2 AVN conduction.
Journal ArticleDOI
Outcome of catheter ablation in the very elderly-insights from a large matched analysis
Kevin Willy,Gerrit Frommeyer,Dirk G. Dechering,Kristina Wasmer,Dennis Höwel,Sarah S Welle,Nils Bögeholz,Christian Ellermann,Julian Wolfes,Benjamin Rath,Patrick Leitz,Julia Köbe,Philipp S. Lange,Patrick Müller,Florian Reinke,Lars Eckardt +15 more
TL;DR: Ablation emerged as first line therapy in the treatment of various arrhythmias, but in older patients (pts), decision is often made pro drug treatment as more complications and less benefit are suspected.